OncoSec Medical Inc (ONCSQ)

[chickpea598]

I think what Oncosec has to offer is better than what Abbvie got for 5.8 Billion dollars for (Rova-T) in Stemcentrx deal. Big letdown after Asco data.

Analyst quote:
"Similar to chemotherapy, Rova-T appears to deliver responses that are transient and don’t translate into long-term survival benefits," wrote Cowen analyst Steve Scala in his note downgrading AbbVie stock to market perform from outperform.

Imagine the value of Oncosec at 5.8 Billion dollars. Not out of the question with the huge market they are targeting....and a lot of room for expansion beyond melanoma.

I think it is going to get a lot more exciting to be an Oncosec shareholder very soon. I would suggest not selling any shares even after data release next month if this pops. I am holding long-term.